@article{ATM22757,
author = {Alessandro Leonetti and Francesco Facchinetti and Marcello Tiseo},
title = {Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?},
journal = {Annals of Translational Medicine},
volume = {6},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {In the last 10 years, the prognosis of advanced non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations has dramatically improved, since the introduction of selective EGFR-tyrosine kinase inhibitors (TKIs).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/22757}
}